MYOVANT SCIENCES LTD's ticker is MYOV and the CUSIP is G637AM102. A total of 100 filers reported holding MYOVANT SCIENCES LTD in Q2 2020. The put-call ratio across all filers is 1.56 and the average weighting 1.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $1,135,000 | +44.4% | 63,204 | 0.0% | 0.02% | +64.3% |
Q2 2022 | $786,000 | -6.7% | 63,204 | 0.0% | 0.01% | +7.7% |
Q1 2022 | $842,000 | -14.4% | 63,204 | 0.0% | 0.01% | -7.1% |
Q4 2021 | $984,000 | -30.6% | 63,204 | 0.0% | 0.01% | -33.3% |
Q3 2021 | $1,418,000 | -1.5% | 63,204 | 0.0% | 0.02% | +10.5% |
Q2 2021 | $1,439,000 | +10.6% | 63,204 | 0.0% | 0.02% | +5.6% |
Q1 2021 | $1,301,000 | -25.5% | 63,204 | 0.0% | 0.02% | -25.0% |
Q4 2020 | $1,746,000 | +148.4% | 63,204 | +26.4% | 0.02% | +118.2% |
Q3 2020 | $703,000 | -33.8% | 50,000 | -2.9% | 0.01% | -31.2% |
Q2 2020 | $1,062,000 | – | 51,500 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blackcrane Capital, LLC | 142,065 | $2,924,000 | 4.61% |
Tri Locum Partners LP | 321,101 | $6,608,000 | 1.64% |
PFM Health Sciences, LP | 2,054,928 | $42,290,000 | 1.29% |
Bellevue Group AG | 5,194,039 | $106,893,000 | 1.13% |
Pier Capital, LLC | 554,779 | $11,417,000 | 1.08% |
Opaleye Management Inc. | 249,800 | $5,141,000 | 0.76% |
Evolution Wealth Advisors, LLC | 140,227 | $2,886,000 | 0.64% |
Hennion & Walsh Asset Management, Inc. | 399,330 | $8,218,000 | 0.49% |
Cormorant Asset Management, LP | 1,000,000 | $20,580,000 | 0.46% |
Integral Health Asset Management, LLC | 65,000 | $1,338,000 | 0.38% |